Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Cowman, Alan
Item TypeName
Academic Article Targeted disruption of maebl in Plasmodium falciparum.
Academic Article Type II fatty acid synthesis is essential only for malaria parasite late liver stage development.
Academic Article Reticulocyte-binding protein homologue 1 is required for sialic acid-dependent invasion into human erythrocytes by Plasmodium falciparum.
Academic Article Negative selection using yeast cytosine deaminase/uracil phosphoribosyl transferase in Plasmodium falciparum for targeted gene deletion by double crossover recombination.
Academic Article Negative selection of Plasmodium falciparum reveals targeted gene deletion by double crossover recombination.
Academic Article Disruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasites.
Academic Article Gene deletion from Plasmodium falciparum using FLP and Cre recombinases: implications for applied site-specific recombination.
Academic Article Analysis of structure and function of the giant protein Pf332 in Plasmodium falciparum.
Academic Article Characterization of a conserved rhoptry-associated leucine zipper-like protein in the malaria parasite Plasmodium falciparum.
Academic Article Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design.
Concept Gene Deletion
Academic Article First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers.
Academic Article A next-generation genetically attenuated Plasmodium falciparum parasite created by triple gene deletion.
Search Criteria
  • Gene Deletion
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.